Search

Results 1-10 of 16
Publication DateTitleAuthor(s)
31-Mar-2015Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode PsychosisMondelli, V; Ciufolini, S; Belvederi Murri, M; Bonaccorso, S; Di Forti, M, et al
28-Nov-2013The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trialChen, L; Johnston, JA; Kinon, BJ; Stauffer, V; Succop, P, et al
11-Aug-2015A Neuroanatomical Signature for Schizophrenia Across Different Ethnic GroupsGong, Q; Dazzan, P; Scarpazza, C; Kasai, K; Hu, X, et al
22-Oct-2012Social Disadvantage: Cause or Consequence of Impending Psychosis?Stilo, SA; Di Forti, M; Mondelli, V; Falcone, AM; Russo, M, et al
19-Feb-2016Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.Marques, TR; Natesan, S; Niccolini, F; Politis, M; Gunn, RN, et al
27-Nov-2015Effect of high-potency cannabis on corpus callosum microstructureRigucci, S; Marques, TR; Di Forti, M; Taylor, H; Dell'Acqua, F, et al
1-Jan-2016Microglial activity in people at ultra high risk of psychosis and in schizophrenia; an [11C]PBR28 PET brain imaging studyBloomfield, P; Sudhakar, S; Veronese, V; Rizzo, G; Bertoldo, A, et al
6-Mar-2018Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measuresOsimo, E; Beck, K; Reis Marques, T; Howes, OD
3-Oct-2017The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disordersKokkinou, M; Ashok, AH; Howes, OD
1-May-2017Association of stimulants use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysisAshok, AH; Mizuno, Y; Volkow, ND; Howes, OD